Stock Market Reviews

Read and share opinions on VRAX (Virax Biolabs Group Limited) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mar

Latest News

• Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes
  Nov 3, 2025
• Virax Biolabs (VRAX) Falls 18% on Lack of Leads
  Aug 27, 2025
• Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September
  Aug 26, 2025
• EXCLUSIVE: Virax Biolabs Inks Research Pact To Advance Long COVID Diagnostic Studies
  Aug 26, 2025
• Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy
  Jul 29, 2025
• Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
  Jul 18, 2025
• Virax Biolabs Group Full Year 2025 Earnings: Misses Expectations
  Jul 4, 2025
• Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating
  Mar 31, 2025
• Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes
  Mar 18, 2025
• Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting
  Mar 13, 2025
• Virax Biolabs to Present at 19th World Immune Regulation Meeting
  Mar 5, 2025
• Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy
  Feb 25, 2025
• EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency
  Feb 25, 2025
• Cosmos Health secures exclusive distribution agreement with Virax Biolabs
  Jan 14, 2025
• Virax Biolabs' CEO James Foster Issues Letter to Shareholders
  Dec 17, 2024
• Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland
  Dec 10, 2024